Management Team

Karen Pignet-Aiach

Founder, Chair and CEO

Founder, Chair, and CEO of Lysogene, Ms. Karen Pignet-Aiach is also the mother of a child with MPS IIIA.

Read bio

Stéphane Durant des Aulnois

Chief Financial Officer

Stéphane Durant des Aulnois joined Lysogene in October 2019 as Chief Financial Officer, also supervising the Alliance Management and Business Development departments.

Read bio

Ralph Laufer

Chief Scientific Officer

Dr. Ralph Laufer is responsible for Lysogene’s scientific activities.

Read bio

Marie Deneux

Chief regulatory officer

Dr. Marie Deneux is in charge of defining and executing the regulatory strategy for the development and registration…

Read bio

Michaël Hocquemiller

Head of Non-Clinical Development

Dr. Michaël Hocquemiller is in charge of the non-clinical development of Lysogene’s gene therapy products including…

Read bio

Marie Trad

Chief clinical officer

Dr. Marie Trad, M.D., Chief Medical Officer is responsible for Lysogene’s medical and clinical development activities…

Read bio

Lysogene COVID-19 update

Find out More

Lysogene is developing therapies for children with CNS diseases.

Delivering Gene Therapy’s Promise

About Us
Our Science
Meet the Team
Diseases
Resources

Contact Us
Careers
Transparency
Compassionate Use Policy

©2022 Lysogene. All rights reserved.

Cookie Policy
Privacy Policy
Legal Notice

Get In Touch

Don’t hesitate to contact us if you need more help.

    Start Typing